Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.lasalabs.com | |
Market Cap | 105.34 Cr. | |
Enterprise Value(EV) | 103.52 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -2.73 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 31.95 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 0.81 | Calculated using Price: 25.90 |
Dividend Yield | 0.97 | Period Ending 2022-03 |
No. of Shares Subscribed | 4.07 Cr. | 40,672,668 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is specialises in ‘catalyst chemistry' and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India |
1 Day |
|
-0.19% |
1 Week |
|
+0.38% |
1 Month |
|
-20.45% |
3 Month |
|
-22.68% |
6 Month |
|
-35.90% |
1 Year |
|
-62.07% |
2 Year |
|
-68.86% |
5 Year |
|
-85.54% |
10 Year |
|
7 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 8.65 | 14.33 | -10.81 | 2.94 | 15.17 | -3.49 | ||
Return on Capital Employed (%) | 14.45 | 12.80 | -3.73 | 6.77 | 17.14 | -3.54 | ||
Return on Assets (%) | 2.07 | 4.79 | -4.44 | 1.50 | 10.43 | -2.64 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 0 | 75 | 117 | 105 | 141 | 159 | 149 | 130 | |
Non Curr. Liab. | 0 | 83 | 62 | 43 | 11 | 8 | 7 | 8 | |
Curr. Liab. | 70 | 107 | 107 | 76 | 41 | 44 | 43 | ||
Minority Int. | |||||||||
Equity & Liab. | 0 | 228 | 287 | 255 | 229 | 208 | 199 | 181 | |
Non Curr. Assets | 149 | 178 | 170 | 153 | 144 | 127 | 137 | ||
Curr. Assets | 0 | 79 | 109 | 86 | 76 | 64 | 72 | 44 | |
Misc. Exp. not W/O | 0 | ||||||||
Total Assets | 0 | 228 | 287 | 255 | 229 | 208 | 199 | 181 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 199 | 244 | 170 | 167 | 202 | 137 | 129 | ||
Other Income | 2 | 3 | 1 | 0 | 0 | 0 | 0 | ||
Total Income | 201 | 247 | 170 | 167 | 203 | 137 | 130 | ||
Total Expenditure | -153 | -202 | -159 | -137 | -155 | -121 | -128 | ||
PBIDT | 48 | 45 | 12 | 30 | 47 | 16 | 1 | ||
Interest | -12 | -11 | -8 | -8 | -2 | 0 | -1 | ||
Depreciation | -8 | -18 | -19 | -17 | -16 | -14 | -13 | ||
Taxation | 0 | -3 | 4 | -1 | -7 | 1 | 0 | ||
Exceptional Items | -26 | -8 | 2 | ||||||
PAT | 2 | 12 | -12 | 4 | 23 | -5 | -11 | ||
Adjusted EPS | 472 | 5 | -5 | 1 | 6 | -1 | -3 |
Particulars | 7 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -3 | 40 | 41 | 14 | 41 | 10 | |
Cash Fr. Inv. | 0 | -44 | -7 | -2 | -4 | -3 | ||
Cash Fr. Finan. | 0 | 0 | 4 | -33 | -10 | -36 | 0 | |
Net Change | 0 | -3 | 0 | 0 | 2 | 1 | 7 | |
Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 3 | 4 | 11 |
Fri, 20 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022 received from Bigshare Services Private Limited Registrar and Share Transfer Agent of the Company. |
Sat, 31 Dec 2022
Closure of Trading Window This is to inform you that as per the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations 2015 as amended the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. January 01 2023 till 48 hours after the declaration of unaudited financial results (both days inclusive) for the quarter ended December 31 2022. |
Sat, 24 Dec 2022
Disclosure Under Reg 30 Of SEBI (Listing Obligations And Disclosure Requirements ) Regulations 2015 Regarding Approval Of Scheme Of Amalgamation By Thehon'Ble NCLT Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to Inform you that The Scheme of Amalgamation of Harishree Aromatics and Chemicals Private Limited the Transferor Company with Lasa Supergenerics Limited the Transferee Company is approved by Honble National Company Law Tribunal Mumbai Bench on Friday December 23 2022 |
Fri, 27 Jan 2023 |
|
|
|
|
|